Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

SHA:603439 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	48.72	46.25	274.03	292.7	201.28	152.28
Depreciation & Amortization	74.02	74.02	75.72	36.9	16.19	11.17
Other Amortization	0.9	0.9	0.29	0.69	1.66	0.04
Loss (Gain) From Sale of Assets	0.12	0.12	0.17	-0.59	0.09	0.15
Asset Writedown & Restructuring Costs	122.01	122.01	0.57	0.05	0.18	0.01
Loss (Gain) From Sale of Investments	2.62	2.62	-1.96	-55.16	-10.96	-17.87
Provision & Write-off of Bad Debts	-5.58	-5.58	9.9	3.35	10.3	0.99
Other Operating Activities	60.67	34.46	31.51	10.89	-3.95	4.79
Change in Accounts Receivable	196.23	196.23	-295.56	-124.07	-79.55	-83.04
Change in Inventory	92.68	92.68	-147.99	-7.06	-9.45	-41.13
Change in Accounts Payable	-408.69	-408.69	167.69	119.02	161.24	127.24
Change in Other Net Operating Assets	13.73	13.73	0.15	4.14	6.3	0.76
Operating Cash Flow	193.25	164.58	107.07	276.7	293.29	155.04
Operating Cash Flow Growth	125.02%	53.71%	-61.30%	-5.66%	89.17%	145.13%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-25.89	-25.84	-45.2	-108.73	-119.91	-26.08
Sale of Property, Plant & Equipment	0.07	0.64	0.55	2.05	0.18	0.05
Cash Acquisitions	-	-	-	-543.04	-160.04	-
Divestitures	-0.09	-0.09	-	-0.01	0.65	-
Investment in Securities	-30.97	-203.8	-59.96	34.5	38	80.7
Other Investing Activities	-122.69	0.66	1.61	1.45	1.92	-34.08
Investing Cash Flow	-179.59	-228.44	-103	-613.78	-266.56	20.59

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	-	-	-	-	200
Long-Term Debt Issued	-	570.54	351.22	504	205	-
Total Debt Issued	518.53	570.54	351.22	504	205	200
Short-Term Debt Repaid	-	-	-	-	-	-200
Long-Term Debt Repaid	-	-422.94	-309.7	-205.45	-200	-
Total Debt Repaid	-527.15	-422.94	-309.7	-205.45	-200	-200
Net Debt Issued (Repaid)	-8.61	147.6	41.52	298.55	5	-
Issuance of Common Stock	-	-	39.23	-	-	26.55
Repurchase of Common Stock	-7.73	-7.73	-100.41	-30	-	-
Common Dividends Paid	-160.64	-161.44	-104.04	-50.92	-8.92	-110.21
Dividends Paid	-160.64	-161.44	-104.04	-50.92	-8.92	-110.21
Other Financing Activities	-0.23	-	23.12	120	3.8	2.2
Financing Cash Flow	-177.22	-21.57	-100.6	337.63	-0.12	-81.46

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	-163.55	-85.43	-96.53	0.55	26.6	94.17

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	167.36	138.74	61.87	167.97	173.38	128.96
Free Cash Flow Growth	269.53%	124.23%	-63.16%	-3.12%	34.45%	1017.56%
Free Cash Flow Margin	9.99%	8.15%	2.89%	10.27%	14.43%	13.73%
Free Cash Flow Per Share	0.40	0.33	0.15	0.41	0.42	0.31
Levered Free Cash Flow	143.7	-57.52	97.61	-36.78	127.68	54.78
Unlevered Free Cash Flow	151.6	-50.6	106.74	-34.2	130.96	59.99

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	185.89	191.18	210.8	175.31	116.04	100.28
Change in Working Capital	-110.22	-110.22	-283.17	-12.13	78.49	3.47

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error